Full metadata record

DC Field Value Language
dc.contributor.authorHuang, Minghua-
dc.contributor.authorSuk, Dae-Hwan-
dc.contributor.authorCho, Nam-Chul-
dc.contributor.authorBhattarai, Deepak-
dc.contributor.authorKang, Soon Bang-
dc.contributor.authorKim, Youseung-
dc.contributor.authorPae, Ae Nim-
dc.contributor.authorRhim, Hyewhon-
dc.contributor.authorKeum, Gyochang-
dc.date.accessioned2024-01-20T07:30:18Z-
dc.date.available2024-01-20T07:30:18Z-
dc.date.created2021-09-04-
dc.date.issued2015-04-01-
dc.identifier.issn0960-894X-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/125559-
dc.description.abstractA series of azacyclic compounds substituted with isoxazole and 5-substituted isoxazolines were synthesized as acyclic modifications of the oxime class M-1 mACh receptor agonist. Among them, 3-(tetrahydropyrin-3-yl)-5-(2-pyrrolodin-1-yl) isoxazoline compound 4f displayed potent and selective M1 mACh receptor agonist activity in the functional calcium mobilization assay (EC50 = 31 nM). Introduction of 2-pyrrolidinone and 3-tetrahydropyridine groups are pivotal to the high potency. Moreover, 4f was found to facilitate non-amyloidogenic amyloid precursor protein (APP) processing by significantly increasing ERK1/2 phosphorylation and sAPP alpha secretion, known disease-modifying effects related to M1 mAChR agonists in Alzheimer's disease (AD). (C) 2015 Elsevier Ltd. All rights reserved.-
dc.languageEnglish-
dc.publisherPergamon Press Ltd.-
dc.subjectAMYLOID PRECURSOR PROTEIN-
dc.subjectALLOSTERIC MODULATION-
dc.subjectCEREBROSPINAL-FLUID-
dc.subjectALZHEIMERS-DISEASE-
dc.subjectACTIVATION-
dc.subjectBETA-
dc.subjectPHARMACOLOGY-
dc.subjectCOGNITION-
dc.subjectEMPHASIS-
dc.subjectKINASE-
dc.titleSynthesis and biological evaluation of isoxazoline derivatives as potent M-1 muscarinic acetylcholine receptor agonists-
dc.typeArticle-
dc.identifier.doi10.1016/j.bmcl.2015.02.012-
dc.description.journalClass1-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry Letters, v.25, no.7, pp.1546 - 1551-
dc.citation.titleBioorganic & Medicinal Chemistry Letters-
dc.citation.volume25-
dc.citation.number7-
dc.citation.startPage1546-
dc.citation.endPage1551-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000351688700036-
dc.identifier.scopusid2-s2.0-84925460879-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.type.docTypeArticle-
dc.subject.keywordPlusAMYLOID PRECURSOR PROTEIN-
dc.subject.keywordPlusALLOSTERIC MODULATION-
dc.subject.keywordPlusCEREBROSPINAL-FLUID-
dc.subject.keywordPlusALZHEIMERS-DISEASE-
dc.subject.keywordPlusACTIVATION-
dc.subject.keywordPlusBETA-
dc.subject.keywordPlusPHARMACOLOGY-
dc.subject.keywordPlusCOGNITION-
dc.subject.keywordPlusEMPHASIS-
dc.subject.keywordPlusKINASE-
dc.subject.keywordAuthormAChR receptor-
dc.subject.keywordAuthorM-1 agonist-
dc.subject.keywordAuthor2-Pyrrolidone-
dc.subject.keywordAuthorIsoxazoline-
dc.subject.keywordAuthorAmyloid precursor protein-
Appears in Collections:
KIST Article > 2015
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE